Evaluating uric acid levels helps clinicians assess metabolic health, renal function, and inflammatory burden. It is commonly used to investigate:
• Gout and crystal-induced joint pain
• Chronic kidney disease or impaired renal clearance
• Metabolic syndrome and insulin resistance
• Hypertension and cardiovascular risk
• High purine intake or alcohol use
• Unexplained fatigue, inflammation, or joint discomfort
Uric acid is increasingly recognized as more than a gout marker—it can reflect broader metabolic and cardiometabolic patterns.
High Uric Acid Levels: Levels above ~6.8–7.0 mg/dL exceed the solubility threshold and increase the risk of crystal formation. Elevated uric acid is associated with gout, uric acid kidney stones, hypertension, endothelial dysfunction, increased cardiovascular event risk, insulin resistance, metabolic syndrome, and impaired renal clearance. Beyond these associations, uric acid serves as a marker of broader vascular and metabolic stress.
In oncology settings, rapid cell turnover—such as in leukemia, lymphoma, or during chemotherapy—can lead to acute hyperuricemia and tumor lysis syndrome, a condition that may result in renal failure if not closely monitored and managed. In pregnancy, elevated uric acid levels may be observed in preeclampsia or eclampsia and can reflect underlying endothelial dysfunction and hypertensive complications, particularly in high-risk patients. Postmenopausal women may also exhibit increased uric acid levels, likely due to reduced estrogen-mediated excretion.
Uric acid should be interpreted within a broader metabolic, renal, and clinical context rather than as an isolated marker. Elevated levels often reflect upstream drivers such as insulin resistance, high fructose intake, alcohol use, medication effects, or reduced kidney function. Determining the underlying cause of elevation is clinically useful; a 24-hour urine uric acid collection can help differentiate between overproduction and underexcretion.
Medication review also plays an important role, as certain agents—including diuretics, low-dose aspirin, and niacin—can raise uric acid levels, while others such as losartan and fenofibrate may contribute to lowering them. Closer monitoring may be warranted in higher-risk populations, including oncology patients, individuals with renal impairment, and those with high-risk pregnancies. It is also worth noting that even high-normal uric acid levels may signal early metabolic or vascular dysfunction.
Clinical management often focuses on improving insulin sensitivity, dietary patterns, hydration status, and renal clearance rather than targeting uric acid in isolation. Monitoring trends over time can provide more meaningful insight into overall metabolic health and treatment response.
• Men: ~4.0–6.5 mg/dL
• Women: ~3.5–5.5 mg/dL
Note: Reference ranges vary by laboratory. In functional medicine, some providers may consider a narrower interpretive window to help guide clinical context. These values are not standardized and should be interpreted in conjunction with the ordering provider’s judgment.
"Elevated uric acid is linked to hypertension, endothelial dysfunction, and cardiovascular risk, and requires close monitoring in high cell turnover states (e.g., chemotherapy) due to risk of tumor lysis syndrome and renal failure; levels may also rise in preeclampsia and postmenopausal women, are influenced by medications, and can be further evaluated with a 24-hour urine test to distinguish overproduction from underexcretion."
Dr. Mitch Ghen - Director of Physician Consultations, Access Labs
Disclaimer: Content on the Access Labs blog is for informational purposes only and reflects the views of individual contributors, not necessarily those of Access Labs. We do not endorse specific treatments, products, or protocols. This content is not a substitute for professional medical advice. Always consult a qualified healthcare provider regarding any medical concerns.